Sucralfate oral suspension
NDC 68462-827, sucralfate, suspension, from Glenmark Pharmaceuticals Inc., USA.
- Product NDC
- 68462-827
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212141
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUCRALFATE1 g/10mL
Pharmacologic classes
Aluminum Complex [EPC]; Organometallic Compounds [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-827-61 | 68462082761 | 420 mL in 1 BOTTLE (68462-827-61) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1e595c2a-edd0-43f7-a2db-69553b9557d9
Use it
Look up 68462-827 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-827. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.